Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030
owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic. Highlighted with 84 tables and 73 figures, this 165-page report “Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
 
Get HOLISTIC Request Sample of This Business Report: https://axelreports.com/request-sample/105479
In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Vaccines • Anthrax • Smallpox • Botulism • Nuclear/Radiation • E-Bola • Zika • Other Vaccines Biothreat Detection Devices • Detectors/Triggering Devices • Assays and Reagents • Samplers • Identifiers Antibiotics Masks Other Products
Based on Sales Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Online Sales • Offline Sales Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Military • Civilian

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Sales Channel, Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global biodefense market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
 
Get HOLISTIC Request Customization of This Business Report: https://axelreports.com/request-customization/105479
Key Players

Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc.General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation

 
About Axel Report:
Axel Reports is committed to being the key player in your company, offering you detailed information on products, market trends, competitors and customers. We offer premium progressive statistical surveys, market research reports, analysis and forecast data for industries and governments around the world. By allowing you to make well-informed choices, Axel Reports will help you develop a great successful marketing project. Axel Reports understands how crucial statistical tracking information is for any association or organization.
Contact Us:
Axel Reports  India Office Office No. P-221, Marvel Sangria Boulevard N.I.B.M. Road Pune -411060 India +18488639402 +18488639402 [email protected]
[email protected]